Evidence map›Paper›PMID 40280242›Full record

ReviewNeurotoxicology2025

Developmental neurotoxicity of bisphenol F and bisphenol S in animal model systems: A literature review.

Ricardo Cantua, Kimberly Mulligan

Abstract readReview
In one paragraph

Review in Neurotoxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ricardo CantuaDepartment of Biological Sciences, California State University, Sacramento, 6000 J Street, Sacramento, CA 95819, USA. Electronic address: rcantuapina@csus.edu.
Kimberly MulliganDepartment of Biological Sciences, California State University, Sacramento, 6000 J Street, Sacramento, CA 95819, USA. Electronic address: kimberly.mulligan@csus.edu.

Funding

Establishing Drosophila melanogaster as a model for determining gene-environment interactions that confer risk of autism using bisphenols and the autism risk gene, fragile x mental retardation 1SC2GM132005 · NIGMS · CALIFORNIA STATE UNIVERSITY SACRAMENTO · PI MULLIGAN, KIMBERLY ANNE · 2019 to 2021
$426k
NIGMS NIH HHS SC2 GM132005
6 · The paper itself

Abstract

Neurodevelopmental disorders have complex etiologies, stemming both from genetic and environmental risk factors, including gestational exposure to bisphenol A (BPA). BPA is an endocrine-disrupting chemical widely used in the synthesis of plastics and epoxy-resins. In 2012, the Food and Drug Administration issued a ban on the use of BPA in certain baby and childhood products, which contributed to the proliferation of BPA-free products. To make products without BPA, plastic and epoxy manufacturers often use chemical analogs, including bisphenol F (BPF) and bisphenol S (BPS). However, the structural and biochemical similarities BPF and BPS share with BPA suggest they may have similar molecular and cellular impacts on the developing nervous system, despite consumers generally regarding BPA-free products as safer alternatives. In this review, we synthesized all available peer-reviewed primary literature to date reporting on the neurodevelopmental impacts of BPF and/or BPS in animal models. In total, 61 papers were identified as relevant to the topic, including evaluation of BPF- and BPS-associated neurodevelopmental phenotypes such as changes in neurodevelopmental gene expression, the proliferation and differentiation of neural stem cells, synaptogenesis, central nervous system morphology, neuronal cell death, and behavior. Though less extensively studied than BPA, the collective works described here indicate that BPF and BPS can act as developmental neurotoxicants in animal models, urging further mechanistic and epidemiological analyses of these bisphenol analogs, as well as a reconsideration by regulatory agencies of policies surrounding their usage.

Indexed as

Benzhydryl CompoundsEndocrine DisruptorsNeurodevelopmental DisordersNeurotoxicity SyndromesPhenolsSulfonesAnimalsBisphenol F CompoundsBisphenol S CompoundsDisease Models, AnimalFemaleHumansPregnancyBenzhydryl Compoundsbisphenol FBisphenol F Compoundsbisphenol SBisphenol S CompoundsEndocrine DisruptorsPhenolsSulfonesBehaviorBisphenol FBisphenol SEndocrine disruptorsNeural stem cellsNeurodevelopmentSynapse

Identifiers

PMID40280242
PMCPMC13553036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.